Pharmacology and Toxicology
-
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
This article has 9 authors:Reviewed by ScreenIT
-
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
This article has 10 authors:Reviewed by ScreenIT
-
Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike – ACE2 Protein-Protein Interaction – A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19
This article has 3 authors:Reviewed by ScreenIT
-
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug
This article has 8 authors:Reviewed by ScreenIT
-
Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders
This article has 5 authors:Reviewed by ScreenIT
-
A phenomics approach for in vitro antiviral drug discovery
This article has 9 authors:Reviewed by ScreenIT
-
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Development of a highly sensitive bioanalytical assay for the quantification of favipiravir
This article has 11 authors:Reviewed by ScreenIT
-
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
This article has 23 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs
This article has 6 authors:Reviewed by ScreenIT